New slide deck uploaded today. Quick comparison from the January slides, here are the updates I found:

Slide 3: Basket trial added vs. few individual cancers and updated to Phase 2. Coronavirus added and noted as Phase 2! Other autoimmune diseases added and in pre-clinical phase.

Slide 5: “final two portions to be submitted in Dec 2019”…..obviously wrong and backtracked from Jan 2019 on the previous slides that stated January 2020.

Slide 6: “Daily lifetime dosing with only 35% of patients having complete viral load suppression”…..added in 35%.

Slide 13: changed slightly noting the ~22 solid tumor cancers section.

Slide 14: added autoimmune section…..states pre-clinical data on over 10 potential indications.

Slide 16: Mr. Timmins replaced Mr. Klump on BOD.

Slide 17: slight change to mission statement.

https://content.equisolve.net/_8e6a4aec71bc8c...r_2020.pdf

Awesome news about patient 1 in remission!! This market is crazy and presented a great buying/adding opportunity IMO. I couldn’t help but grab a few more myself!!